Role of intravenous immunoglobulin in the treatment of Kawasaki disease

E-ISSN： 1756-185x|21|1|64-69

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.21, Iss.1, 2018-01, pp. : 64-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunoglobulin G Values before Treatment Are Correlated With the Responsiveness to Initial Intravenous Immunoglobulin Therapy for Kawasaki Disease

International Archives of Allergy and Immunology, Vol. 164, Iss. 2, 2014-06 ,pp. : 83-88

Karger

Access to resources Recommend Favorite

Intravenous immunoglobulin–related hemolysis in patients treated for Kawasaki disease

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S90-S94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persistent Endothelial Damage after Intravenous Immunoglobulin Therapy in Kawasaki Disease

International Archives of Allergy and Immunology, Vol. 165, Iss. 2, 2014-11 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Identification of an Association Between Genomic Hypomethylation of FCGR2A and Susceptibility to Kawasaki Disease and Intravenous Immunoglobulin Resistance by DNA Methylation Array

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 3, 2015-03 ,pp. : 828-836

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated d‐Dimer Level is a Risk Factor for Coronary Artery Lesions Accompanying Intravenous Immunoglobulin‐Unresponsive Kawasaki Disease

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 2, 2015-04 ,pp. : 171-177

John Wiley & Sons Inc

Access to resources Recommend Favorite